Monosialyl Ganglioside GM3 Decreases Apolipoprotein B-100 Secretion in Liver Cells

Abstract

Some sialic acid-containing glycolipids are known to regulate development of atherosclerosis with accumulated plasma apolipoprotein B-100 (Apo-B)-containing lipoproteins, because Apo-B as an atherogenic apolipoprotein is assembled mainly in VLDL and LDL. Previously, we have elucidated that disialyl GD3 promotes the microsomal triglyceride transfer protein (MTP) gene expression and secretion of triglyceride (TG)-assembled ApoB, claiming the GD3 role in ApoB lipoprotein secretion in liver cells. In the synthetic pathway of gangliosides, GD3 is synthesized by addition of a sialic acid residue to GM3. Thus, there should be some regulatory links between GM3 and GD3. In this study, exogenous and endogenous monosialyl GM3 has been examined how GM3 plays a role in ApoB secretion in Chang liver cells in a view point of MTP and ApoB degradation in the same cells. The level of GM3 ganglioside in the GM3 synthase gene-transfected cells was increased in the cell extract, but not in the medium. In addition, GM3 synthase gene-transfected cells showed a diminished secretion of TG-enriched ApoB with a lower content of TG in the medium. Exogenous GM3 treatment for 24 h exerted a dose dependent inhibitory effect on ApoB secretion together with TG, while a liver-specific albumin was unchanged, indicating that GM3 effect is limited to ApoB secretion. GM3 decreased the mRNA level of MTP gene, too. ApoB protein assembly dysregulated by GM3 indicates the impaired ApoB secretion is caused by a proteasome-dependent pathway. Treatment with small interfering RNAs (siRNAs) decreased ApoB secretion, but GM3-specific antibody did not. These results indicate that plasma membrane associated GM3 inhibits ApoB secretion, lowers development of atherosclerosis by decreasing the secretion of TG-enriched ApoB containing lipoproteins, suggesting that GM3 is an inhibitor of ApoB and TG secretion in liver cells. J. Cell. Biochem. 118: 2168-2181, 2017. © 2017 Wiley Periodicals, Inc.

Transcriptional Activation of Human GD3 Synthase (hST8Sia I) Gene in Curcumin-Induced Autophagy in A549 Human Lung Carcinoma Cells

“…The nucleus was stained with 4′,6-diamidino-2-phenylindole (DAPI) at room temperature for 10 min. Fluorescence images were acquired using a LSM 700 confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany), as described in [ 46 , 47 ].…”

Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice

“…15 While gangliosides are present in the liver 16 , little is known about the impact of gangliosides or their regulatory proteins in hepatic lipid metabolism in vivo. There is some evidence that GM3 inhibits apolipoprotein B secretion in liver cells 17 and might regulate hepatic cholesterol metabolism. 18 In light of these observations, the aim of this study was to examine the role of HEXA in hepatic lipid metabolism.…”

Selective Inhibitors of Human Neuraminidase 1 (NEU1)

“…Four isoenzymes of human NEU (hNEU) have been reported: NEU1, NEU2, NEU3, and NEU4 . Since the discovery of human NEU genes almost 20 years ago, investigations of their function have implicated these enzymes in diseases including disorders of metabolism, inflammation, cancer, diabetes, − and atherosclerosis. − Although these four isoenzymes vary in their tissue expression, subcellular location, and substrate specificity, their precise biochemical roles remain to be clearly elucidated. , Our group has continued to pursue the development of small molecule inhibitors with selectivity for individual isoenzymes in the hNEU family to be used as research tools to reveal the specific roles of these enzymes …”